A 54-year-old woman comes to the clinic reporting a 2-month history of progressive weakness, particularly when climbing stairs and brushing her hair. She also notes a new rash on her face and hands. Her medical history is unremarkable, and she takes no medications. Physical examination reveals an erythematous, violaceous rash on her upper eyelids and scaling, erythematous plaques over her metacarpophalangeal and proximal interphalangeal joints. Muscle strength is 3/5 in the proximal upper and lower extremities bilaterally, and 5/5 in the distal extremities. Sensation is intact, and deep tendon reflexes are 2+ bilaterally.
| Test | Result | Reference Range |
|---|---|---|
| Creatine kinase | 4,500 U/L | 30-170 U/L |
| Thyroid-stimulating hormone | 2.1 mU/L | 0.5-5.0 mU/L |
| Free T4 | 1.2 ng/dL | 0.9-1.7 ng/dL |
| Antinuclear antibodies | Positive | Negative |
The physician diagnoses the patient with dermatomyositis and plans to initiate high-dose oral prednisone. Which of the following is the most appropriate additional step in the management of this patient?
- AAdministration of broad-spectrum antibiotics
- BAdministration of the live-attenuated influenza vaccine
- Screening for an underlying malignancyAnswer
- DInitiation of levothyroxine therapy
- EReassurance regarding the benign nature of the skin findings